Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

NCT07341191

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • University Health Network Toronto, Ontario, Canada
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04910568

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope - Lennar Foundation Cancer Center Irvine, California, United States
  • Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver, Colorado, United States
  • Karmanos Cancer Institute. Detroit, Michigan, United States
View all 34 locations
View Trial Details

Related conditions